Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
International Journal of Molecular Sciences · 05.02.2023 · 24 (4) · 3140
DOI: 10.3390/ijms24043140 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.02.2023. Verfasst von Rok Herman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Hyperandrogenism, Insulin Resistance. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research Agency.
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in women of reproductive age. Its heterogeneous clinical presentation is characterized by hyperandrogenemia, reproductive changes, polycystic ovary morphology, and insulin resistance (IR). The primary pathophysiological process in its multifactorial etiology has not yet been identified. However, the two most proposed core etiologies are the disruption of insulin metabolism and hyperandrogenemia, both of which begin to intertwine and propagate each other in the later stages of the disease. Insulin metabolism can be viewed as the interconnectedness of beta cell function, IR or insulin sensitivity, and insulin clearance. Previous studies of insulin metabolism in PCOS patients have yielded conflicting results, and literature reviews have focused mainly on the molecular mechanisms and clinical implications of IR. In this narrative review, we comprehensively explored the role of insulin secretion, clearance, and decreased sensitivity in target cells as a potential primary insult in PCOS pathogenesis, along with the molecular mechanism behind IR in PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
- Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
ORCID-Profile: Rok Herman, Jaka Sikonja, Mojca Jensterle, Andrej Janez, Vita Dolzan
Förderung
- Slovenian Research Agency
Zitieren
APA
Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023). Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance. International Journal of Molecular Sciences, 24(4), 3140. https://doi.org/10.3390/ijms24043140
Vancouver
Herman R, Sikonja J, Jensterle M, Janez A, Dolzan V. Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance. International Journal of Molecular Sciences. 2023;24(4):3140. doi:10.3390/ijms24043140
BibTeX
@article{Herman2023,
author = {Herman, Rok and Sikonja, Jaka and Jensterle, Mojca and Janez, Andrej and Dolzan, Vita},
title = {Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3140},
doi = {10.3390/ijms24043140}
}
EUVIMED